Prevention of estradiol-induced endometrial hyperplasia with either transdermal norethisterone acetate (NETA) 120μg or oral promegestone 500μG

Autor:	A. Conesa, J. Calaf, Jean-Pierre Raynaud, B. Sarrazin, C. Pelissier, M. Levrier
Rok vydání:	2000
Předmět:	medicine.medical_specialty business.industry Obstetrics and Gynecology General Medicine Promegestone medicine.disease Norethisterone acetate Endometrial hyperplasia chemistry.chemical_compound Endocrinology chemistry Internal medicine medicine business Transdermal medicine.drug
Zdroj:	International Journal of Gynecology & Obstetrics. 70:E13-E13
ISSN:	0020-7292
DOI:	10.1016/s0020-7292(00)82358-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b0c5ba18d08845519a9bfece3a621d54 https://doi.org/10.1016/s0020-7292(00)82358-9 Zobrazit plný text záznamu Plný text